Gene: FAM8A1
Official Full Name: family with sequence similarity 8 member A1provided by HGNC
Gene Summary: Predicted to be involved in ERAD pathway. Part of Hrd1p ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22537 | FAM8A1 Knockout cell line (HeLa) | Human | FAM8A1 | 1:3~1:6 | Negative | Online Inquiry |
KO22538 | FAM8A1 Knockout cell line (HCT 116) | Human | FAM8A1 | 1:2~1:4 | Negative | Online Inquiry |
KO22539 | FAM8A1 Knockout cell line (HEK293) | Human | FAM8A1 | 1:3~1:6 | Negative | Online Inquiry |
KO22540 | FAM8A1 Knockout cell line (A549) | Human | FAM8A1 | 1:3~1:4 | Negative | Online Inquiry |
FAM8A1 Gene Knockout Cell Lines are a cutting-edge tool designed for researchers investigating the functional roles of the FAM8A1 gene in various biological processes. The FAM8A1 gene, implicated in diverse cellular pathways including cell proliferation, differentiation, and survival, is essential for understanding its contribution to diseases such as cancer and developmental disorders. These knockout cell lines are generated using CRISPR-Cas9 technology, ensuring precise gene editing that eliminates FAM8A1 expression, allowing for the assessment of gene function and downstream effects in a controlled environment.
The primary function of FAM8A1 Gene Knockout Cell Lines lies in their ability to create a cellular model devoid of FAM8A1, which enables researchers to elucidate the gene's mechanisms of action and its impact on cellular signaling pathways. These cell lines facilitate studies on gene interactions, therapeutic targets, and biomarker identification, making them invaluable for both basic and translational research.
The scientific importance of FAM8A1 knockout models is underscored by their applications in drug discovery and the development of targeted therapies. By providing a clear understanding of the gene's role, these cell lines can accelerate the identification of potential therapeutic targets, particularly in oncology and regenerative medicine.
One of the significant advantages of our FAM8A1 Gene Knockout Cell Lines is the reliability and reproducibility afforded by using state-of-the-art gene editing techniques. Unlike traditional knockout methods that can produce mixed cellular populations, our product delivers a homogeneous cell line that enhances experimental consistency. Furthermore, these lines are validated for specific cellular characteristics, providing researchers with high-quality controls to conclusively interpret their results.
Researchers and clinicians will find substantial value in utilizing FAM8A1 Gene Knockout Cell Lines for their ability to simplify complex studies, allowing for deeper insights into gene function and therapeutic implications. Understanding FAM8A1's role in pathology can lead to groundbreaking advancements in disease treatment.
At [Your Company Name], we pride ourselves on our expertise in developing innovative biological products that empower scientific exploration. Our commitment to quality and precision positions us as a trusted partner in advancing research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.